5 results on '"Eirini-Sofia Karampi"'
Search Results
2. Working conditions and insomnia: the case of Greek hospital physicians
- Author
-
Martha Andritsou, Nicolaos Laschos, Spyridon Mentzelopoulos, S. Zakynthinos, Adamantia Sotiriou, Katerina Baou, Eirini-Sofia Karampi, Eleni Perraki, Eleni Loutrari, and Emmanouil Vagiakis
- Subjects
medicine.medical_specialty ,business.industry ,Family medicine ,Insomnia ,medicine ,medicine.symptom ,business - Published
- 2020
3. Nitrofurantoin-induced acute pulmonary toxicity
- Author
-
Panagiota Styliara, Elias Kainis, Kyriaki Tavernaraki, Eirini-Sofia Karampi, Konstantinos Livanios, and Adamantia Sotiriou
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Pulmonary toxicity ,Interstitial lung disease ,Emergency department ,medicine.disease ,humanities ,03 medical and health sciences ,0302 clinical medicine ,Bronchoalveolar lavage ,Nitrofurantoin ,Internal medicine ,Anesthesia ,medicine ,Acute respiratory failure ,030212 general & internal medicine ,business ,030217 neurology & neurosurgery ,medicine.drug ,Pneumonitis - Abstract
We report a case of a female admitted to the emergency department with fever and severe type I acute respiratory failure. After detailed examination, all other potential causes were excluded and the patient was diagnosed with nitrofurantoin-induced acute pulmonary toxicity.
- Published
- 2016
4. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers
- Author
-
Petros Karakitsos, Evangelia Douka, Marinella Tzanela, Vassiliki Papaevangelou, Frantzeska Frantzeskaki, Sofia Tsaousi, Eirini-Sofia Karampi, Dimitra Vassiliadi, Christina Routsi, Christina Kottaridi, Nikitas Nikitas, Ioannis Ilias, Maria Alepaki, Ioanna Dimopoulou, Apostolos Armaganidis, and Vasiliki Gennimata
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Organ Dysfunction Scores ,medicine.medical_treatment ,Critical Illness ,Multiple Organ Failure ,Population ,Congenital cytomegalovirus infection ,Cytomegalovirus ,Critical Care and Intensive Care Medicine ,Real-Time Polymerase Chain Reaction ,law.invention ,Young Adult ,law ,Risk Factors ,Internal medicine ,medicine ,Humans ,Prospective Studies ,Zinc Oxide-Eugenol Cement ,education ,Saliva ,Aged ,Mechanical ventilation ,Aged, 80 and over ,education.field_of_study ,business.industry ,Incidence (epidemiology) ,Incidence ,Organ dysfunction ,Immunosuppression ,Odds ratio ,Middle Aged ,medicine.disease ,Intensive care unit ,Respiration, Artificial ,Intensive Care Units ,Immunology ,Cytomegalovirus Infections ,DNA, Viral ,Cytokines ,Female ,Virus Activation ,medicine.symptom ,business ,Immunocompetence ,Biomarkers - Abstract
Purpose Cytomegalovirus (CMV) reactivation, a significant cause of morbidity and mortality in immunosuppression, may affect “immunocompetent” seropositive critically ill patients. The aim of this prospective, observational study was to define the incidence, risk factors, and the association with morbidity and mortality of CMV reactivation in a general population of critically ill immunocompetent patients. We also studied the relationship between reactivation and patients' inflammatory response, as expressed by cytokine levels and stress up-regulation by salivary cortisol. Methods This study included mechanically ventilated CMV-seropositive patients. A quantitative real-time polymerase chain reaction (PCR) was performed for CMV plasma DNAemia determination, upon intensive care unit (ICU) admission and weekly thereafter until day 28. Cytomegalovirus reactivation was defined as CMV plasma DNAemia greater than or equal to 500 copies/mL. Upon ICU admission, interferon γ, interleukin (IL) 10, IL-17A, IL-2, IL-6, and tumor necrosis factor α were quantified in plasma, and morning saliva was obtained to measure cortisol. Disease severity was assessed by Acute Physiology and Chronic Health Evaluation II score, whereas the degree of organ dysfunction was quantified by Sequential Organ Failure Assessment score. Mortality, duration of mechanical ventilation, and ICU length of stay were recorded. Results During the study period, 80 (51 men) patients with a median age of 63 years fulfilled the inclusion criteria. Reactivation of CMV occurred in 11 patients (13.75%). Median day of reactivation was day 7 post ICU admission. Total number of red blood cell units transfused (odds ratio [OR], 1.50; confidence interval [CI], 1.06-2.13; P = .02) and C-reactive protein levels upon ICU admission (OR, 1.01; CI, 1.00-1.02; P = .02) were independently associated with CMV reactivation. High IL-10 was marginally related to reactivation (P = .06). Sequential Organ Failure Assessment scores were higher in the group with CMV reactivation compared with patients without reactivation during the entire 28-day observation period (P < .006). Salivary cortisol, mortality, length of ICU stay, and duration of mechanical ventilation were similar in the 2 groups. Conclusions Cytomegalovirus reactivation occurred in 13.75% of critically ill, immunocompetent patients. The degree of inflammation and the total number of transfused red blood cells units constituted risk factors. Cytomegalovirus reactivation was associated with more severe of organ dysfunction, but not with a worse clinical outcome.
- Published
- 2014
5. Acrometastases
- Author
-
Apostolos Armaganidis, Panayiotis J. Papagelopoulos, Zinon T. Kokkalis, George Mimidis, Andreas F. Mavrogenis, Irene Karampela, and Eirini-Sofia Karampi
- Subjects
medicine.medical_specialty ,Disarticulation ,medicine.medical_treatment ,Bone Neoplasms ,Ulna ,Metastasis ,Renal cell carcinoma ,medicine ,Humans ,Orthopedics and Sports Medicine ,Embolization ,Leg Bones ,business.industry ,Foot Bones ,Cancer ,medicine.disease ,Prognosis ,Nephrectomy ,Radiation therapy ,Radiography ,Radius ,Amputation ,Hand Bones ,Surgery ,Radiology ,business - Abstract
Metastases distal to the elbow and the knee (acrometastases) are rare, accounting for approximately 0.1 % of all cases. Acrometastases can appear in patients of every age, with men being twice as likely as women to be affected. The most common primary cancer site is the lung (>50 %), followed by the colon, breast and genito-urinary tract. They mainly appear in cancer patients with wide-spread disseminated disease. Rarely, they may be the first presentation of occult silent cancer, mimicking a benign condition. Current evidence supports that the tumor cells reach the bones of the hands through the circulation and not the lymphatic system; the malignant cells from the lungs have an easy access through the arterial circulation of the arms. The rare incidence of foot acrometastases is believed to be due to the lack of red marrow in these bones, a further distance from the primary cancer site, and the valveless paravertebral venous plexuses (Batson’s plexuses), which allow retrograde tumor cell embolization through the iliofemoral venous system. Treatment depends on staging and tumor extent. Amputative surgery is the more common approach, especially for cancers with poor response to radiation therapy and chemotherapy. In the majority of cases, disarticulation of the ray is required to achieve wide margin resection. In the foot, amputation can be that of a ray, midfoot or transtibial, depending on the location and spread of the tumor. If unresectable, palliative treatment with radiation therapy, bisphosphonates and chemotherapy is recommended. The prognosis of the patients with acrometastatic cancer is poor; the mean survival time after diagnosis is
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.